KUALA LUMPUR: Pharmaniaga Bhd yesterday said its subsidiary Pharmaniaga Manufacturing Bhd (PMB) has been issued the 2010 manufacturing licence after a satisfactory follow-up audit undertaken by the Health Ministry’s (MOH) pharmaceutical services division.

In a statement, Pharmaniaga said the follow-up audit on the good manufacturing practices (GMP) of PMB was carried out on March 10 and the licence was issued yesterday.

“We hope with the issuance of the 2010 manufacturing licence, our customers will continue to have confidence in us,” said Pharmaniaga managing director Mohamad Abdullah. Pharmaniaga said moving forward, it would ensure full compliance with all the requirements of GMP under guidelines of “PIC/S Guide to GMP for Medicinal Products”.

The licence was revoked with effect from March 1 after a recent routine audit by MOH’s pharmaceutical services division at Pharmaniaga’s plant in Bangi. The ministry found a “few non-compliance issues”.

Pharmaniaga later said the revocation was the result of critical findings over the storage and segregation of rejected and quarantined material and products, and the handling of rejected and recalled materials and products. The stock yesterday closed unchanged at RM4.41 with 25,000 shares traded.

This article appeared in The Edge Financial Daily, March 16, 2010.